Combination treatment for metastatic melanoma results in longer overall survival

Among patients with metastatic melanoma, treatment with a combination of the drugs sargramostim plus ipilimumab, compared with ipilimumab alone, resulted in longer overall survival and lower toxicity, but no difference in progression-free survival, according to a study. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *